Dasatinib Export Market Intelligence: India's 110 Suppliers Shipping to 71 Countries — TransData Nexus 2026

Q: Who are the top dasatinib exporters from India?

The top dasatinib exporters from India are: 1. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $3.0M (18.5% market share); 2. DR.REDDY'S LABORATORIES LTD — $3.0M (18.5% market share); 3. MSN LABORATORIES PRIVATE LIMITED — $2.6M (16.2% market share); 4. EUGIA PHARMA SPECIALITIES LIMITED — $2.2M (13.3% market share); 5. SUN PHARMACEUTICAL INDUSTRIES LTD — $2.0M (12.0% market share). Together they account for 78.5% of India's total dasatinib export value.

Q: What is the total export value of dasatinib from India?

The total export value of dasatinib from India is $16.4M USD, recorded across 508 shipment transactions from 110 active exporters to 71 destination countries. The average shipment value is $32.3K.

Q: Which countries import dasatinib from India?

India exports dasatinib to 71 countries worldwide. The top importing countries are: UNITED STATES (31.7% share, $5.2M), CANADA (20.1% share, $3.3M), AUSTRALIA (12.9% share, $2.1M), MEXICO (10.4% share, $1.7M), BELGIUM (5.8% share, $947.7K). These five markets account for 80.9% of total export value.

Q: What is the HS code for dasatinib exports from India?

The primary HS code for dasatinib exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of dasatinib exports from India?

The average unit price for dasatinib exports from India is $71.99 USD per unit, with prices ranging from $0.01 to $2000.00 depending on formulation, packaging, and order volume. The total market is valued at $16.4M across 508 shipments.

Q: Which ports handle dasatinib exports from India?

The primary ports for dasatinib exports from India are SAHAR AIR CARGO ACC (INBOM4) (17.9% of shipments), SAHAR AIR (17.7% of shipments), HYDERABAD ACC (INHYD4) (12.4% of shipments), DELHI AIR (7.7% of shipments), DELHI AIR CARGO ACC (INDEL4) (7.1% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of dasatinib?

India is one of the world's leading exporters of dasatinib due to its large base of 110 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports dasatinib to 71 countries, demonstrating 36% global market coverage.

Q: What certifications do Indian dasatinib exporters need?

Indian dasatinib exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import dasatinib from India?

There are 177 registered buyers importing dasatinib from India, spread across 71 countries. The repeat buyer rate is 57.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top dasatinib supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading dasatinib exporter from India with a market share of 18.5% and total export value of $3.0M across 36 shipments. The top 5 suppliers together control 78.5% of total export value.

Suresh Sormare

Dasatinib

India Pharmaceutical Trade Intelligence

$16.4M110 Suppliers71 CountriesHS 30049049

ExportsIndia → UNITED STATES31.7%India → CANADA20.1%

ImportsUNITED STATES → India$2.5M GERMANY → India$325.1K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: TARO PHARMACEUTICALS

Dasatinib Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Dasatinib to the World

Between 2022 and 2026, India exported $16.4M worth of dasatinib across 508 verified shipments to 71 countries — covering 36% of world markets in the Advanced Oncology segment. The largest destination is UNITED STATES (31.7%). SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 18.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Dasatinib export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Dasatinib export data snapshot — $16.4M · 110 exporters · 71 countriesTransData Nexus · Indian Customs Data

Top Dasatinib Exporters from India

110 active exporters · Ranked by export value

View all 110 →

Top Dasatinib Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$3.0M	36	7	18.5%
2	DR.REDDY'S LABORATORIES LTD

Top Countries Importing Dasatinib from India

71 destination markets · Ranked by import value

All 71 countries →

Top Countries Importing Dasatinib from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$5.2M	31.7%
2	CANADA	$3.3M	20.1%
3	AUSTRALIA	$2.1M	12.9%
4	MEXICO	$1.7M	10.4%
5	BELGIUM	$947.7K	5.8%
6	GUATEMALA	$837.0K	5.1%
7	SOUTH AFRICA	$569.1K	3.5%
8	PERU	$364.1K	2.2%
9	MALTA	$343.6K	2.1%
10	SRI LANKA	$262.7K	1.6%

UNITED STATES is India's largest dasatinib export destination, absorbing 31.7% of total exports worth $5.2M. The top 5 importing countries — UNITED STATES, CANADA, AUSTRALIA, MEXICO, BELGIUM — together account for 80.9% of India's total dasatinib export value. The remaining 66 destination countries collectively receive the other 19.1%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Dasatinib to India?

15 origin countries · Total import value: $3.6M

India imports dasatinib from 15 countries with a combined import value of $3.6M. The largest supplier is UNITED STATES ($2.5M, 47 shipments), followed by GERMANY and IRELAND. All values are from Indian Customs (DGFT) import records.

Countries Supplying Dasatinib to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$2.5M	47	68.9%
2	GERMANY	$325.1K	8	9.1%
3	IRELAND	$286.3K	14	8.0%
4	CANADA	$151.9K	4	4.2%
5	CZECH REPUBLIC	$104.9K	8	2.9%
6	UNITED KINGDOM	$98.4K	2	2.7%
7	BRAZIL	$57.7K	6	1.6%
8	HUNGARY	$56.4K	1	1.6%
9	SINGAPORE	$13.7K	1	0.4%
10	DENMARK	$9.3K	1	0.3%

Showing top 10 of 15 origin countries

UNITED STATES is the largest supplier of dasatinib to India, accounting for 68.9% of total import value. The top 5 origin countries — UNITED STATES, GERMANY, IRELAND, CANADA, CZECH REPUBLIC — together supply 93.1% of India's dasatinib imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Dasatinib

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, dasatinib is approved under the brand name Sprycel. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for generic versions of dasatinib. For instance, ANDA 203180 for Dasatinib Tablets, 80 mg and 140 mg, was approved for Apotex Corp., indicating the presence of generic competition in the market. The regulatory pathway for dasatinib involves demonstrating bioequivalence to the reference listed drug, Sprycel, and compliance with FDA manufacturing standards. Notably, the substantial number of Indian exporters supplying dasatinib to the U.S. underscores India's significant role in the generic pharmaceutical market.

2EU & UK Regulatory Framework

In the European Union, dasatinib is marketed under the brand name Sprycel, with marketing authorization granted on 20 November 2006. Generic versions, such as Dasatinib Accord, received marketing authorization on 24 March 2022; however, this authorization was withdrawn on 25 March 2023 at the request of the marketing authorization holder, Accord Healthcare S.L.U., due to commercial reasons. The European Medicines Agency (EMA) requires compliance with Good Manufacturing Practice (GMP) standards for all medicinal products, ensuring quality and safety. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization and regulation of pharmaceuticals, adhering to similar stringent standards as the EMA.

3WHO Essential Medicines & Global Standards

Dasatinib is included in the World Health Organization's Model List of Essential Medicines, highlighting its importance in treating leukemia. While specific editions of the list should be consulted for the most current information, its inclusion signifies global recognition of its therapeutic value. Compliance with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is essential for dasatinib manufacturers to ensure product quality and facilitate international trade.

4India Regulatory Classification

In India, dasatinib is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The Drug Price Control Order (DPCO), enforced by the National Pharmaceutical Pricing Authority (NPPA), regulates the pricing of essential medicines; however, specific ceiling prices for dasatinib should be verified with the latest NPPA notifications. For export purposes, Indian pharmaceutical companies must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and international standards.

5Patent & Exclusivity Status

Dasatinib's primary patents have expired, leading to increased generic competition globally. For example, U.S. Patent Number 7,491,725 expired on 28 September 2026, and Patent Number 8,680,103 expired on 4 August 2025. The expiration of these patents has allowed multiple manufacturers to enter the market, increasing accessibility and affordability of dasatinib.

6Recent Industry Developments

In March 2023, the European Commission withdrew the marketing authorization for Dasatinib Accord at the request of Accord Healthcare S.L.U., citing commercial reasons. This decision reflects the dynamic nature of the pharmaceutical market and the strategic decisions companies make regarding product portfolios.

In January 2026, the EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the marketing authorization for Iclusig (ponatinib), another tyrosine kinase inhibitor. The new indication includes treatment for adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) who are resistant to dasatinib or nilotinib, highlighting the evolving treatment landscape for CML.

These developments underscore the importance of staying informed about regulatory changes and market dynamics to navigate the complex pharmaceutical landscape effectively.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Dasatinib

Retail & reference prices across 9 markets vs. India FOB export price of $71.99/unit

Global Price Benchmark for Dasatinib across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Pricing information for Dasatinib in the United States is not publicly disclosed by government agencies.
United Kingdom	N/A	GBP	The UK's National Health Service (NHS) Drug Tariff does not list specific prices for Dasatinib.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) does not publicly disclose pricing information for Dasatinib.
Australia	N/A

Supply Chain Risk Assessment — Dasatinib

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Dasatinib, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70-80% of India's API and KSM requirements are sourced from China, creating a significant dependency on Chinese suppliers. This reliance exposes the supply chain to risks associated with geopolitical tensions, trade disputes, and regulatory changes in China.

Recent disruptions have highlighted the vulnerabilities in this dependency. For instance, in March 2026, the closure of the Strait of Hormuz due to escalating conflicts led to significant delays and increased costs in the transportation of raw materials. This event underscored the fragility of supply chains reliant on specific geographic routes and suppliers.

2Supplier Concentration & Single-Source Risk

The export data for Dasatinib from India reveals a high supplier concentration, with the top five exporters accounting for 78.5% of the total export value. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with an 18.5% share, followed closely by DR. REDDY'S LABORATORIES LTD at 18.5%, MSN LABORATORIES PRIVATE LIMITED at 16.2%, EUGIA PHARMA SPECIALITIES LIMITED at 13.3%, and SUN PHARMACEUTICAL INDUSTRIES LTD at 12.0%. This concentration indicates a significant single-source risk, where disruptions affecting these key players could have a substantial impact on the global supply of Dasatinib.

Access Complete Dasatinib Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 508 transactions across 71 markets.

Request Demo View Pricing

Frequently Asked Questions — Dasatinib Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top dasatinib exporters from India?

The leading dasatinib exporters from India are SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR.REDDY'S LABORATORIES LTD, MSN LABORATORIES PRIVATE LIMITED, and 11 others. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 18.5% market share ($3.0M). The top 5 suppliers together control 78.5% of total export value.

What is the total export value of dasatinib from India?

The total export value of dasatinib from India is $16.4M, recorded across 508 shipments from 110 active exporters to 71 countries. The average shipment value is $32.3K.

Which countries import dasatinib from India?

India exports dasatinib to 71 countries. The top importing countries are UNITED STATES (31.7%), CANADA (20.1%), AUSTRALIA (12.9%), MEXICO (10.4%), BELGIUM (5.8%), which together account for 80.9% of total export value.

What is the HS code for dasatinib exports from India?

The primary HS code for dasatinib exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Dasatinib

Dasatinib

Top Dasatinib Exporters from India

Top Countries Importing Dasatinib from India

Who Supplies Dasatinib to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Dasatinib

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Dasatinib

Supply Chain Risk Assessment — Dasatinib

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Dasatinib Trade Intelligence

Frequently Asked Questions — Dasatinib Exports from India

Who are the top dasatinib exporters from India?

What is the total export value of dasatinib from India?

Which countries import dasatinib from India?

What is the HS code for dasatinib exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of dasatinib exports from India?

Which ports handle dasatinib exports from India?

Why is India a leading exporter of dasatinib?

What certifications do Indian dasatinib exporters need?

How many buyers import dasatinib from India?

What is the market share of the top dasatinib exporter from India?

Analysis Methodology